Trial Profile
Boceprevir Early-Access For Advanced Fibrosis/Cirrhosis In Asia-Pacific HCV Genotype 1 Non-Responders/Relapser Patients (Beacon Study)
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary)
- Indications Hepatitis C
- Focus Expanded access; Therapeutic Use
- Acronyms BEACON
- 31 Aug 2015 New trial record